La. provider to install $40M IBA-Philips proton therapy room

IBA Group, which develops cancer diagnosis and therapy technologies, and Royal Philips Electronics will install a patient-centered proton therapy treatment room. The addition to the Willis-Knighton Cancer Center in Shreveport, La., will incorporate the Philips Ambient Experience.

Designed and engineered by Philips Healthcare, the Philips Ambient Experience permits patients to add light, sound and images to the treatment room. 

Willis-Knighton will utilize ProteusOne*, IBA’s single-room compact gantry technology. The $40 million project is expected to begin treating cancer patients with protons in early 2014.

Together with Philips, IBA is demonstrating a of the ProteusOne proton therapy room combined with the Philips Ambient Experience solution in booth #3019 at the 54th annual American Society for Radiation Oncology (ASTRO) meeting in Boston.

*ProteusONE is the brand name of a new configuration of the Proteus235, including some developments subject to review by the regulatory bodies, including the FDA and European Commission, before marketing.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.